RCC
Les récepteurs des chimiokines C-C (CCRs) sont un groupe de GPCR qui répondent aux chimiokines, des molécules de signalisation qui guident la migration des cellules immunitaires vers les sites d'inflammation ou d'infection. Les CCR jouent un rôle crucial dans les réponses immunitaires, l'inflammation et le développement de diverses maladies, y compris les troubles auto-immuns et le cancer. La modulation de l'activité des CCR est explorée comme une stratégie thérapeutique pour des affections telles que la polyarthrite rhumatoïde, la sclérose en plaques et l'infection par le VIH. Chez CymitQuimica, nous offrons une gamme de modulateurs de CCR de haute qualité pour soutenir vos recherches en immunologie, inflammation et développement thérapeutique.
154 produits trouvés pour "RCC".
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
ML604086
CAS :ML604086 suppresses CCL1 mediated chemotaxis and enhances intracellular Ca2 concentrations.Formule :C27H32N4O4SDegré de pureté :99.91%Couleur et forme :White SolidMasse moléculaire :508.63RS102895 hydrochloride
CAS :RS102895 hydrochloride is a potent antagonist of CCR2(IC50 of 360 nM).Formule :C21H22ClF3N2O2Degré de pureté :98.95%Couleur et forme :SolidMasse moléculaire :426.86INCB-9471
CAS :INCB-9471 is a CCR5 antagonist with anti-HIV activity and inhibits the interaction between HIV-1 gp120.Formule :C30H40F3N5O2Degré de pureté :98.89%Couleur et forme :White SolidMasse moléculaire :559.666AZ084
CAS :AZ084 is a potent, selective, allosteric, and oral active CCR8 antagonist (Ki: 0.9 nM). It has the potential to treat asthma.Formule :C26H34N4O2Degré de pureté :97.12%Couleur et forme :White SolidMasse moléculaire :434.57Ref: TM-T10425
1mg66,00€5mg142,00€1mL*10mM (DMSO)158,00€10mg202,00€25mg358,00€50mg530,00€100mg745,00€J-113863
CAS :J-113863 is also a potent antagonist of the human CCR3 (IC50 of 0.58 nM) , but a weak antagonist of the mouse CCR3 (IC50 of 460 nM).Formule :C30H37Cl2IN2O2Degré de pureté :95.11%Couleur et forme :SolidMasse moléculaire :655.44Ref: TM-T11699
1mg56,00€2mg82,00€5mg119,00€10mg160,00€1mL*10mM (DMSO)170,00€25mg288,00€50mg500,00€100mg718,00€CCR2-RA-[R]
CAS :CCR2-RA-[R] is a C-C chemokine receptor type 2 (CCR2) allosteric antagonist (IC50: 103 nM).Formule :C18H19ClFNO3Degré de pureté :99.7%Couleur et forme :White SolidMasse moléculaire :351.8Leronlimab
CAS :Leronlimab (PRO 140), a humanized IgG4 monoclonal antibody, targets CCR5 to combat HIV and cancer.Degré de pureté :SDS-PAGE:95.0%;SEC-HPLC:99.6%Couleur et forme :Transparent LiquidMasse moléculaire :146.66 kDaMogamulizumab
CAS :Mogamulizumab is a monoclonal antibody targeting CC chemokine receptor 4 with anticancer effects, used in ATLL and CTCL studies.Degré de pureté :SDS-PAGE:97.3%;SEC-HPLC:99.4%Couleur et forme :Transparent LiquidMasse moléculaire :146.43 kDaCCX140
CAS :CCX140 (CCX140-B) (CCX140-B) is an antagonist of CCR2.Formule :C20H13ClF3N5O3SDegré de pureté :99.66% - 99.95%Couleur et forme :SolidMasse moléculaire :495.86MK-0812 Succinate
CAS :MK-0812 Succinate is an effective and selective CCR2 antagonist.Formule :C28H40F3N3O7Degré de pureté :98.62% - 99.93%Couleur et forme :SolidMasse moléculaire :587.63CCR4 antagonist 3 hydrochloride
CAS :Orally active CCR4 antagonist 3 hydrochloride with potent selectivity, IC50s: 22/50 nM; has antitumor properties.Formule :C24H27Cl2N7O·xHClCouleur et forme :SolidMet-RANTES,human,acetate
Met-RANTES (human) acetate is the acetate salt form of Met-RANTES (human). It acts as an antagonist for CCR1 and CCR5 receptors. This compound inhibits the human chemokines MIP-1α and MIP-1β, with respective IC50 values of 5 and 2 nM. Additionally, Met-RANTES (human) acetate reduces bone destruction and alleviates adjuvant-induced arthritis (AIA) in rats.Couleur et forme :Odour SolidMLN-3897 TFA
MLN-3897 TFA is a potent CCR1 antagonist that inhibits the binding of 125I-MIP-1α to THP-1 cell membranes.Formule :C32H32ClF3N2O6Degré de pureté :99.80%Couleur et forme :SolidMasse moléculaire :633.05Ref: TM-T28072L
1mg109,00€5mg233,00€1mL*10mM (DMSO)319,00€10mg344,00€25mg532,00€50mg735,00€100mg982,00€200mg1.333,00€CCR4 antagonist 3
CAS :Orally active CCR4 antagonist with piperidinyl-azetidine; IC50: 22 nM (calcium flux), 50 nM (CTX); antitumor effects.Formule :C24H27Cl2N7OCouleur et forme :SolidMasse moléculaire :500.43CAP-100
CAP-100 is a monoclonal antibody targeting CCR7. It neutralizes the ligand binding site and signaling of CCR7. This compound effectively inhibits migration, extravasation, homing, and survival in chronic lymphocytic leukemia (CLL) samples induced by CCR7. CAP-100 can mediate potent tumor cell killing through host immune mechanisms and exhibits favorable toxicity profiles in related hematopoietic cell subsets. It is involved in research on antitumor activity and diseases like chronic lymphocytic leukemia (CLL).Couleur et forme :Odour LiquidBertilimumab
CAS :Bertilimumab (CAT 213; iCo-008), a human monoclonal antibody that targets eotaxin-1 (CCL11), shows promise in the research of allergic disorders [1].Couleur et forme :LiquidZn-DPA-maytansinoid conjugate 1
Zn-DPA-maytansinoid 1 targets checkpoints, shrinks tumors, and heats TME.Formule :C115H145ClN18O31S2Zn2Couleur et forme :SolidMasse moléculaire :2505.83TBK1 degrader-4
TBK1degrader-4 (Compound 30) is a molecular glue degrader targeting TBK1. It effectively inhibits cyst growth, reduces inflammation, and lowers levels of pro-inflammatory factors such as Ccl2, IFNβ, and IL-6. TBK1degrader-4 shows potential for research in autosomal dominant polycystic kidney disease (ADPKD).Couleur et forme :Odour SolidVZMC013
VZMC013 is a potent chemical probe targeting the MOR-CCR5 heterodimer, effectively inhibiting HIV-1 entry exacerbated by opioid compounds. It exhibits nanomolar binding affinity to both MOR and CCR5, inhibits CCL5-activated calcium mobilization, and significantly enhances anti-HIV-1BaL activity compared to previously reported bivalent ligands. In TZM-bl cells co-expressing CCR5 and MOR, VZMC013 demonstrates greater inhibition of viral infection than in cells expressing only CCR5. Additionally, VZMC013 blocks HIV-1 entry into peripheral blood mononuclear cells (PBMC) in a concentration-dependent manner and more effectively inhibits opioid-accelerated HIV-1 entry in phytohemagglutinin-activated PBMC than in opioid-free environments.Formule :C65H92F2N10O10Masse moléculaire :1211.48Aplaviroc hydrochloride
CAS :Aplaviroc, a potent CCR5 inhibitor, binds selectively, blocking HIV entry and specific monoclonal antibody attachment in vitro.Formule :C33H44ClN3O6Couleur et forme :SolidMasse moléculaire :614.17
![CCR2-RA-[R]](https://static.cymitquimica.com/products/TM/thumb-webp/T14900.webp)
